Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Superficial Femoral Artery Stenosis clinical trials

1 of 2 indexed Superficial Femoral Artery Stenosis trials are currently recruiting.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · 1 currently recruiting · #7,188 of 28,707 conditions by registered trial count

Superficial Femoral Artery Stenosis: 2 US clinical trials tracked, 1 recruiting.

Superficial Femoral Artery Stenosis is the subject of 2 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Medinol, running 1 of these trials.

Enrollment posture brief

Registry condition superficial-femoral-artery-stenosis

OPEN 1 | RECR 50% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Superficial Femoral Arte (th…50%
Open-enrollment share among volume-matched conditions near Superficial Femoral Artery Stenosis

Superficial Femoral Artery Stenosis lists 1 open slots (50% of 2 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Superficial Femoral Artery Stenosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Superficial Femoral Artery Stenosis is recruiting above its size-band peers.

    1 of 2 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Medinol 1 trials

Named interventions

Most-linked intervention names on Superficial Femoral Artery Stenosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Selution SLR™ 018 DEB Device
1 trials
ChampioNIR Ridaforolimus Eluting Peripheral Stent System Device
1 trials
Plain (Uncoated) Balloon Angioplasty (PTA) Device
1 trials

US sites by state

Facility locations filed on Superficial Femoral Artery Stenosis trials. A trial with sites in several states counts in each.

New York 2 trials
Georgia 2 trials
New Jersey 1 trials
Missouri 1 trials
Maryland 1 trials
Louisiana 1 trials
Illinois 1 trials
Florida 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Superficial Femoral Artery Stenosis page

2 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Superficial Femoral Artery Stenosis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Medinol sponsors the most Superficial Femoral Artery Stenosis trials on record, review their full trial history before evaluating a specific study. See Medinol's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Superficial Femoral Artery Stenosis condition card totals 2 registered trials; most-linked intervention Selution SLR™ 018 DEB; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.